Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Sanara MedTech Inc.NASDAQ: SMTI

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI remains negative

Q1 FY2026 Accumulated OCI was $0, compared with $0 a year earlier.

Context

  • Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Accumulated OCI increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Accumulated OCI vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
  • Accumulated OCI amounts to 0.0% of total assets for SMTI, versus a peer median of 0.0%.
SMTI Competitors
Accumulated OCI for SMTI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TRDAEntrada Therapeutics, Inc.Mar 2026$246K USD-43.7%—0.1%
NEONeoGenomics, Inc.Jun 2026$4K USD-86.2%—0.0%
SMTISanara MedTech Inc.Mar 2026$0 USD——0.0%
SGHTSight Sciences, Inc.Mar 2026$0 USD——0.0%
VMDViemed Healthcare, Inc.Mar 2026$0 USD——0.0%
HITIHigh Tide Inc.Apr 2026CA$0 CAD-100.0%—0.0%
LFMDLifeMD, Inc.Mar 2026$0 USD——0.0%
XGNExagen Inc.Mar 2026$0 USD——0.0%
STXSStereotaxis, Inc.Mar 2026$0 USD+100.0%—0.0%
TBRGTruBridge, Inc.Mar 2026-$288K USD-838.5%—0.1%
Peer median (excluding SMTI) —-86.2%—0.0%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents18.65M8.96M5.15M15.88M16.58M
Short-term Investments00000
Net Receivables2.99M7M8.53M13.55M12M
Inventory2.05M3.55M4.72M2.75M3.95M
Other Current Assets01.1M608.41K1.12M1.02M
Total Current Assets24.61M20.62M19.01M33.31M33.54M
Property, Plant & Equipment (Net)2.04M2.22M3.25M1.88M2.53M
Goodwill03.6M3.6M3.6M3.6M
Intangible Assets4.73M31.51M44.93M41.01M18.64M
Long-term Investments5.02M3.08M3.08M8.3M14.63M
Tax Assets00000
Other Non-current Assets(1)0000
Total Non-current Assets11.79M40.42M54.87M54.79M39.4M
Total Assets36.4M61.04M73.87M88.09M72.94M
Account Payables593.97K1.43M2M1.5M2.34M
Short-term Debt00580.36K0353.23K
Tax Payables00000
Deferred Revenue002.05M01.23M
Other Current Liabilities01.16M(947.68K)0235K
Total Current Liabilities6.02M12.81M13.77M15.29M18.63M
Long-term Debt009.11M30.69M45.97M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities06M4.66M1.96M548.13K
Total Non-current Liabilities222.15K6.51M15.52M33.89M48.39M
Total Liabilities6.24M19.32M29.28M49.18M67.01M
Common Stock7.68K8.3K8.54K8.75K8.95K
Retained Earnings(15.24M)(23.39M)(28.04M)(37.78M)(75.3M)
Accumulated OCI00000
Other Stockholders Equity0000(8.67K)
Minority Interest(488.4K)(107.56K)(244.26K)(491.61K)(8.67K)
Total Equity30.15M41.72M44.59M38.91M5.93M
Total Debt425.44K819.22K11.79M32.29M48.19M
Net Debt(18.23M)(8.14M)6.64M16.41M31.61M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.